On Mar. 3, 2021, Pfizer and BioNTech, in partnership with UNICEF, announced the arrival of the first doses of their COVID-19 vaccine in Rwanda through the COVAX Facility.

This was the companies’ first delivery to a COVAX Advanced Market Commitment country of their mRNA vaccine. The almost 103,000 doses were to vaccinate at-risk, front-line healthcare workers across the country.